Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD19-PD-1/CD28-CAR T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
CD19-PD-1/CD28-CAR T cells consist of autologous T-lymphomcytes engineered to produce a chimeric antigen receptor (CAR) with an anti-CD19 fragment and a PD-1/CD28 chimeric switch-receptor, which may lead to potential cytotoxic activity against tumor cells expressing PD-L1 (PMID: 33028589). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD19-PD-1/CD28-CAR T cells | CD19-PD-1/CD28-CAR T cells | 2 | 0 |